Suppr超能文献

相似文献

1
Mycoplasma pneumoniae and its role as a human pathogen.
Clin Microbiol Rev. 2004 Oct;17(4):697-728, table of contents. doi: 10.1128/CMR.17.4.697-728.2004.
3
[Mycoplasma pneumoniae, community-acquired pneumonia and asthma].
Arch Pediatr. 2005 Apr;12 Suppl 1:S7-11. doi: 10.1016/s0929-693x(05)80003-x.
4
Mycoplasma pneumoniae and its role in asthma.
Postgrad Med J. 2007 Feb;83(976):100-4. doi: 10.1136/pgmj.2006.049023.
5
Update on infection and antibiotics in asthma.
Curr Allergy Asthma Rep. 2010 Jan;10(1):67-73. doi: 10.1007/s11882-009-0086-2.
7
Mycoplasma pneumoniae-an emerging extra-pulmonary pathogen.
Clin Microbiol Infect. 2008 Feb;14(2):105-17. doi: 10.1111/j.1469-0691.2007.01834.x. Epub 2007 Oct 19.
8
Pathogenesis of Mycoplasma pneumoniae: An update.
Indian J Med Microbiol. 2016 Jan-Mar;34(1):7-16. doi: 10.4103/0255-0857.174112.
9
Cytokines in Mycoplasma pneumoniae infections.
Cytokine Growth Factor Rev. 2004 Apr-Jun;15(2-3):157-68. doi: 10.1016/j.cytogfr.2004.01.001.

引用本文的文献

1
Biofilms: Characteristics and Control Strategies.
Microorganisms. 2025 Aug 7;13(8):1850. doi: 10.3390/microorganisms13081850.
2
Editorial: Current molecular, immunological, pathological and clinical aspects of pathogenic infections.
Front Cell Infect Microbiol. 2025 Aug 8;15:1665283. doi: 10.3389/fcimb.2025.1665283. eCollection 2025.
4
Case Report: -induced rash and mucositis in a child.
Front Med (Lausanne). 2025 Jul 21;12:1607970. doi: 10.3389/fmed.2025.1607970. eCollection 2025.
6
Epidemiological characteristics of acute viral and mycoplasma respiratory infections in Yongzhou, China: a retrospective descriptive study.
Front Public Health. 2025 Jul 17;13:1614985. doi: 10.3389/fpubh.2025.1614985. eCollection 2025.
7
Modelling immunity gaps to quantify infection resurgences.
R Soc Open Sci. 2025 Jul 16;12(7):250030. doi: 10.1098/rsos.250030. eCollection 2025 Jul.
9
Case Report: Refractory pneumonia complicated by pulmonary embolism and infarction in a child.
Front Pediatr. 2025 Jun 23;13:1608233. doi: 10.3389/fped.2025.1608233. eCollection 2025.
10
Alterations in BCR heavy chain CDR3 repertoire characteristics in pediatric mycoplasma pneumoniae infection.
Front Cell Infect Microbiol. 2025 Jun 12;15:1573511. doi: 10.3389/fcimb.2025.1573511. eCollection 2025.

本文引用的文献

2
Protective Effect of Vaccines in Experimental Mycoplasma pneumoniae Disease.
Infect Immun. 1970 Jun;1(6):559-65. doi: 10.1128/iai.1.6.559-565.1970.
3
Molecular diagnosis of Mycoplasma pneumoniae respiratory tract infections.
J Clin Microbiol. 2003 Nov;41(11):4915-23. doi: 10.1128/JCM.41.11.4915-4923.2003.
4
STUDIES ON MYCOPLASMA PNEUMONIAE INFECTION IN SWEDEN.
Acta Pathol Microbiol Scand. 1965;63:469-75. doi: 10.1111/apm.1965.63.3.469.
5
A NEWLY IDENTIFIED ORAL MYCOPLASMA (M. ORALE) AND ITS RELATIONSHIP TO OTHER HUMAN MYCOPLASMAS.
Am J Hyg. 1964 Jul;80:135-48. doi: 10.1093/oxfordjournals.aje.a120454.
7
Mycoplasma pneumoniae: proposed nomenclature for atypical pneumonia organism (Eaton agent).
Science. 1963 May 10;140(3567):662. doi: 10.1126/science.140.3567.662.
8
Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO.
Proc Natl Acad Sci U S A. 1962 Jan 15;48(1):41-9. doi: 10.1073/pnas.48.1.41.
9
Serologic evidence of infection with Eaton agent in lower respiratory illness in childhood.
N Engl J Med. 1960 Mar 31;262:648-54. doi: 10.1056/NEJM196003312621303.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验